Skip to main content
SpringerLink
Log in

Novel Techniques in the Diagnosis of Inflammatory Bowel Disease

  • Chapter
  • First Online:
Inflammatory Bowel Disease

Part of the book series: Clinical Gastroenterology ((CG))

  • 1773 Accesses

Abstract

Substantial advances in the diagnosis and management of inflammatory bowel disease (IBD) have arisen from novel laboratory and radiographic tests, as well as from endoscopic luminal and mucosal imaging techniques. Serological markers used in combination may be helpful in differentiating between Crohn’s disease and ulcerative colitis. Elevated levels of calprotectin or lactoferrin in the feces may be helpful in assessing disease activity and response to medical therapy in IBD patients. Capsule endoscopy and double-balloon enteroscopy are considered to be complementary in the evaluation of suspected small intestinal disorders. The Consensus Committee on Colorectal Cancer Surveillance in IBD has endorsed the incorporation of chromoendoscopy performed by trained endoscopists for CRC surveillance in patients with ulcerative colitis. CT enterography may be the preferred test in the initial evaluation of suspected small bowel Crohn’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, et al. Sero-reactivity to microbial components in Crohn’s disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004;99(12):2376–84.

    PubMed  Google Scholar 

  2. Reumaux D, Sendid B, Poulain D, Duthilleul P, Dewit O, Colombel JF. Serological markers in inflammatory bowel diseases. Best Pract Res Clin Gastroenterol. 2003;17(1):19–35.

    PubMed  CAS  Google Scholar 

  3. Colombel JF, Reumaux D, Sendid B, et al. Serodiagnostics in IBD. In: Bernstein CN, editor. The inflammatory bowel disease yearbook 2003. London: Remedica; 2003. p. 63–78.

    Google Scholar 

  4. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115(4):822–9.

    PubMed  CAS  Google Scholar 

  5. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96(3):730–4.

    PubMed  CAS  Google Scholar 

  6. Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol. 2002;22(5):281–8.

    PubMed  CAS  Google Scholar 

  7. Mallant-Hent R, Mary B, von Blomberg E, Yuksel Z, Wahab PJ, Gundy C, et al. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol. 2006;18(1):75–8.

    PubMed  CAS  Google Scholar 

  8. Vasiliauskas EA, Kam LY, Karp LC, Gaiennie J, Yang H, Targan SR. Marker antibody expression stratifies Crohn’s disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut. 2000;47(4):487–96.

    PubMed  CAS  Google Scholar 

  9. Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn’s disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol. 2004;135(3):490–6.

    PubMed  CAS  Google Scholar 

  10. Amre DK, Lu SE, Costea F, Seidman EG. Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn’s disease patients. Am J Gastroenterol. 2006;101(3):645–52.

    PubMed  Google Scholar 

  11. Vernier G, Sendid B, Poulain D, Colombel JF. Relevance of serologic studies in inflammatory bowel disease. Curr Gastroenterol Rep. 2004;6(6):482–7.

    PubMed  Google Scholar 

  12. Sandborn WJ, Landers CJ, Tremaine WJ, Targan SR. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol. 1995;90(5):740–7.

    PubMed  CAS  Google Scholar 

  13. Vecchi M, Gionchetti P, Bianchi MB, Belluzzi A, Meucci G, Campieri M, et al. p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis. Lancet. 1994;344(8926):886–7.

    PubMed  CAS  Google Scholar 

  14. Fleshner PR, Vasiliauskas EA, Kam LY, Fleshner NE, Gaiennie J, Abreu-Martin MT, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut. 2001;49(5):671–7.

    PubMed  CAS  Google Scholar 

  15. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, et al. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(2):449–54.

    PubMed  CAS  Google Scholar 

  16. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42(6):788–91.

    PubMed  CAS  Google Scholar 

  17. Sandborn WJ, Loftus Jr EV, Colombel JF, Fleming KA, Seibold F, Homburger HA, et al. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2001;7(3):192–201.

    PubMed  CAS  Google Scholar 

  18. Panaccione R, Sandborn WJ. Is antibody testing for inflammatory bowel disease clinically useful? Gastroenterology. 1999;116(4):1001–2; discussion 1002–3.

    Google Scholar 

  19. Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology. 2002;122(5):1242–7.

    PubMed  Google Scholar 

  20. Esters N, Vermeire S, Joossens S, Noman M, Louis E, Belaiche J, et al. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn’s disease. Am J Gastroenterol. 2002;97(6):1458–62.

    PubMed  CAS  Google Scholar 

  21. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, et al. Selected loss of tolerance evidenced by Crohn’s disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123(3):689–99.

    PubMed  CAS  Google Scholar 

  22. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease. Gastroenterology. 2004;126(2):414–24.

    PubMed  CAS  Google Scholar 

  23. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn’s disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol. 2004;99(11):2235–41.

    PubMed  Google Scholar 

  24. Iltanen S, Tervo L, Halttunen T, Wei B, Braun J, Rantala I, et al. Elevated serum anti-I2 and anti-OmpW antibody levels in children with IBD. Inflamm Bowel Dis. 2006;12(5):389–94.

    PubMed  Google Scholar 

  25. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn’s disease. Gastroenterology. 2005;128(7):2020–8.

    PubMed  CAS  Google Scholar 

  26. Targan SR, Landers CJ, Lodes M, Cong Y, Elson CO, Hershberg R. Antibodies to a novel flagellin (CBir1) define a unique serologic response in Crohn’s disease (CD) [abstract 817]. Gastroenterology. 2004;126(4 Suppl 2):A112.

    Google Scholar 

  27. Andrews AH, Cash BD, Lee DH, Saad R, Rai J, Maydonovitch C, et al. The high false positive rate of inflammatory bowel disease serologic markers in patients with irritable bowel syndrome [abstract 1226]. Am J Gastroenterol. 2006;101(S2):S475.

    Google Scholar 

  28. Austin GL, Shaheen NJ, Sandler RS. Positive and negative predictive values: use of inflammatory bowel disease serologic markers. Am J Gastroenterol. 2006;101(3):413–6.

    PubMed  Google Scholar 

  29. Kaila B, Orr K, Bernstein CN. The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn’s disease and predicting inflammatory disease. Can J Gastroenterol. 2005;19(12):717–21.

    PubMed  Google Scholar 

  30. Brandtzaeg P, Dale I, Fagerhol MK. Distribution of a formalin-resistant myelomonocytic antigen (L1) in human tissues. II. Normal and aberrant occurrence in various epithelia. Am J Clin Pathol. 1987;87(6):700–7.

    PubMed  CAS  Google Scholar 

  31. Striz I, Trebichavsky I. Calprotectin – a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53(3):245–53.

    PubMed  CAS  Google Scholar 

  32. Tibble JA, Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol. 2001;7(4):460–5.

    PubMed  CAS  Google Scholar 

  33. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119(1):15–22.

    PubMed  CAS  Google Scholar 

  34. Gaya DR, Lyon TD, Duncan A, Neilly JB, Han S, Howell J, et al. Faecal calprotectin in the assessment of Crohn’s disease activity. QJM. 2005;98(6):435–41.

    PubMed  CAS  Google Scholar 

  35. Wright JP, Young GO, Tigler-Wybrandi N. Predictors of acute relapse of Crohn’s disease. A laboratory and clinical study. Dig Dis Sci. 1987;32(2):164–70.

    PubMed  CAS  Google Scholar 

  36. Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;32(2):171–7.

    PubMed  CAS  Google Scholar 

  37. Carroccio A, Iacono G, Cottone M, Di Prima L, Cartabellotta F, Cavataio F, et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem. 2003;49(6 Pt 1):861–7.

    PubMed  CAS  Google Scholar 

  38. Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;33(1):14–22.

    PubMed  CAS  Google Scholar 

  39. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion. 1997;58(2):176–80.

    PubMed  CAS  Google Scholar 

  40. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis. 2003;35(9):642–7.

    PubMed  CAS  Google Scholar 

  41. Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease. Gut. 2005;54(3):364–8.

    PubMed  CAS  Google Scholar 

  42. Aadland E, Fagerhol MK. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol. 2002;14(8):823–5.

    PubMed  CAS  Google Scholar 

  43. Roseth AG, Aadland E, Grzyb K. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol. 2004;39(10):1017–20.

    PubMed  CAS  Google Scholar 

  44. Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AA, Cooper WH, et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol. 1992;30(5):1238–42.

    PubMed  CAS  Google Scholar 

  45. Sugi K, Saitoh O, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol. 1996;91(5):927–34.

    PubMed  CAS  Google Scholar 

  46. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003;98(6):1309–14.

    PubMed  CAS  Google Scholar 

  47. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica. 1995;80(3):252–67.

    PubMed  CAS  Google Scholar 

  48. Buderus S, Boone J, Lyerly D, Lentze MJ. Fecal lactoferrin: a new parameter to monitor infliximab therapy. Dig Dis Sci. 2004;49(6):1036–9.

    PubMed  CAS  Google Scholar 

  49. Scarpa M, D’Inca R, Basso D, Ruffolo C, Polese L, Bertin E, et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn’s disease. Dis Colon Rectum. 2007;50(6):861–9.

    PubMed  Google Scholar 

  50. Mishkin DS, Chuttani R, Croffie J, Disario J, Liu J, Shah R, et al. ASGE Technology Status Evaluation Report: wireless capsule endoscopy. Gastrointest Endosc. 2006;63(4):539–45.

    PubMed  Google Scholar 

  51. Appleyard M, Glukhovsky A, Swain P. Wireless-capsule diagnostic endoscopy for recurrent small-bowel bleeding. N Engl J Med. 2001;344(3):232–3.

    PubMed  CAS  Google Scholar 

  52. Gurudu S, Vargas HE, Leighton JA. New frontiers in small bowel imaging. The expanding technology of capsule endoscopy and its impact in clinical gastroenterology. Rev Gastroenterol Disord. 2008;8(1):1–14.

    PubMed  Google Scholar 

  53. Arnott ID, Lo SK. The clinical utility of wireless capsule endoscopy. Dig Dis Sci. 2004;49(6):893–901.

    PubMed  Google Scholar 

  54. Cave D, Fleischer DE, Heigh R, Leighton J, Sharma V, Hibberd P, et al. First study involving simultaneous ingestion of two video capsules (VCs): a comparison of Olympus VC and Given Imaging VC in the detection of obscure GI bleeding (OGIB) [abstract M1320]. Gastrointest Endosc. 2006;63(5):AB171.

    Google Scholar 

  55. Cave DR, Fleischer DE, Gostout CJ, Faigel DO, Leighton JA, Heigh RI, et al. A multi-center randomized comparison of the endocapsule: Olympus Inc and the Pillcam SB: Given Imaging in patients with obscure GI bleeding [abstract 816]. Gastrointest Endosc. 2007;65(5):AB125.

    Google Scholar 

  56. Hartmann D, Eickhoff A, Damian U, Riemann JF. Diagnosis of small-bowel pathology using paired capsule endoscopy with two different devices: a randomized study. Endoscopy. 2007;39(12):1041–5.

    PubMed  CAS  Google Scholar 

  57. Lashner BA. Clinical features, laboratory findings, and course of Crohn’s disease. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia: Saunders; 2000. p. 305–14.

    Google Scholar 

  58. Bourreille A, Jarry M, D’Halluin PN, Ben-Soussan E, Maunoury V, Bulois P, et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study. Gut. 2006;55(7):978–83.

    PubMed  CAS  Google Scholar 

  59. Triester SL, Leighton JA, Leontiadis GI, Gurudu SR, Fleischer DE, Hara AK, et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn’s disease. Am J Gastroenterol. 2006;101(5):954–64.

    PubMed  Google Scholar 

  60. Dubcenco E, Jeejeebhoy KN, Petroniene R, Zalev AH, Gardiner GW, Irvine JE, et al. Diagnosing Crohn’s disease (CD) of the small bowel (SB): should capsule endoscopy (CE) be used? CE vs. other diagnostic modalities [abstract M1813]. Gastrointest Endosc. 2004;59(5):AB174.

    Google Scholar 

  61. Eliakim R, Suissa A, Yassin K, Katz D, Fischer D. Wireless capsule video endoscopy compared to barium follow-through and computerised tomography in patients with suspected Crohn’s disease – final report. Dig Liver Dis. 2004;36(8):519–22.

    PubMed  CAS  Google Scholar 

  62. Toth E, Fork FT, Almqvist P, Benoni C, Ekberg O, Grip O, et al. Wireless capsule enteroscopy: a comparison with enterography, push enteroscopy and ileo-colonoscopy in the diagnosis of small bowel Crohn’s disease [abstract M1809]. Gastrointest Endosc. 2004;59(5):AB173.

    Google Scholar 

  63. Chong AK, Taylor A, Miller A, Hennessy O, Connell W, Desmond P. Capsule endoscopy vs. push enteroscopy and enteroclysis in suspected small-bowel Crohn’s disease. Gastrointest Endosc. 2005;61(2):255–61.

    PubMed  Google Scholar 

  64. Hara AK, Leighton JA, Heigh RI, Sharma VK, Silva AC, De Petris G, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology. 2006;238(1):128–34.

    PubMed  Google Scholar 

  65. Bloom P, Rosenberg M, Klein S, Sitaraman S, Halwan B, Wenger J, et al. Wireless capsule endoscopy (CE) is more informative than ileoscopy and SBFT for the evaluation of the small intestine (SI) in patients with known or suspected Crohn’s disease (CD). Paper presented at International Conference of Capsule Endoscopy, Berlin, Germany; 23–25 March 2003.

    Google Scholar 

  66. Dionisio PM, Leighton JA, Leontiadis GI, Fleischer DE, Hara AK, Heigh RI, et al. Capsule endoscopy (CE) has a significantly higher diagnostic yield in patients with suspected and established non-stricturing Crohn disease (NSCD): a meta-analysis [abstract W1448]. Gastrointest Endosc. 2007;65(5):AB369.

    Google Scholar 

  67. Mow WS, Lo SK, Targan SR, Dubinsky MC, Treyzon L, Abreu-Martin MT, et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2(1):31–40.

    PubMed  Google Scholar 

  68. Voderholzer WA, Beinhoelzl J, Rogalla P, Murrer S, Schachschal G, Lochs H, et al. Small bowel involvement in Crohn’s disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis. Gut. 2005;54(3):369–73.

    PubMed  CAS  Google Scholar 

  69. Kornbluth A, Colombel JF, Leighton JA, Loftus E. ICCE consensus for inflammatory bowel disease. Endoscopy. 2005;37(10):1051–4.

    PubMed  CAS  Google Scholar 

  70. Mascarenhas-Saraiva M, Lopes LM. Wireless capsule endoscopy (WCE) is useful for diagnosis and monitoring of small bowel Crohn’s disease [abstract M1888]. Gastrointest Endosc. 2003;57:AB170.

    Google Scholar 

  71. Hume G, Whitaker D, Radford-Smith G, Appleyard M. Can capsule endoscopy (CE) help differentiate the aetiology of indeterminate colitis (IC)? Paper presented at International Conference of Capsule Endoscopy, Miami, FL; 29 February–3 March 2004.

    Google Scholar 

  72. Maunoury V, Savoye G, Bourreille A, Bouhnik Y, Jarry M, Sacher-Huvelin S, et al. Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified). Inflamm Bowel Dis. 2007;13(2):152–5.

    PubMed  Google Scholar 

  73. Viazis N, Karamanolis DG. Indeterminate colitis – the role of wireless capsule endoscopy. Aliment Pharmacol Ther. 2007;25(7):859; author reply 860.

    Google Scholar 

  74. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol. 2005;3(2):133–41.

    PubMed  Google Scholar 

  75. Solem CA, Loftus EV, Fletcher JG, Baron TH, Gostout CJ, Petersen BT, et al. Small bowel (SB) imaging in Crohn’s disease (CD): a prospective, blinded, 4-way comparison trial [abstract 488]. Gastroenterology. 2005;128(4 Suppl 2):A74.

    Google Scholar 

  76. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol. 2005;3(1):55–9.

    PubMed  Google Scholar 

  77. Gralnek IM, Defranchis R, Seidman E, Leighton JA, Legnani P, Lewis BS. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther. 2008;27(2):146–54.

    PubMed  CAS  Google Scholar 

  78. Buchman AL, Miller FH, Wallin A, Chowdhry AA, Ahn C. Videocapsule endoscopy versus barium contrast studies for the diagnosis of Crohn’s disease recurrence involving the small intestine. Am J Gastroenterol. 2004;99(11):2171–7.

    PubMed  Google Scholar 

  79. Cheifetz AS, Kornbluth AA, Legnani PE, Schmelkin IJ, Lichtiger S, Lewis BS. Incidence and outcome of the retained video capsule endoscope (CE) in Crohn’s disease (CD): is it a “therapeutic complication”? [abstract 807]. Am J Gastroenterol. 2004;99(10):S262.

    Google Scholar 

  80. Leighton JA, Wallace MB. Update on small bowel imaging. Gastroenterology. 2007;132(5):1651–4.

    PubMed  Google Scholar 

  81. Delvaux M, Ben Soussan E, Laurent V, Lerebours E, Gay G. Clinical evaluation of the use of the M2A patency capsule system before a capsule endoscopy procedure, in patients with known or suspected intestinal stenosis. Endoscopy. 2005;37(9):801–7.

    PubMed  CAS  Google Scholar 

  82. Herrerias JM, Leighton JA, Costamagna G, Infantolino A, Eliakim R, Fischer D, et al. Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc. 2008;67(6):902–9.

    PubMed  Google Scholar 

  83. Spada C, Shah SK, Riccioni ME, Spera G, Marchese M, Iacopini F, et al. Video capsule endoscopy in patients with known or suspected small bowel stricture previously tested with the dissolving patency capsule. J Clin Gastroenterol. 2007;41(6):576–82.

    PubMed  Google Scholar 

  84. Yamamoto H, Yano T, Kita H, Sunada K, Ido K, Sugano K. New system of double-balloon enteroscopy for diagnosis and treatment of small intestinal disorders. Gastroenterology. 2003;125(5):1556; author reply 1556–7.

    Google Scholar 

  85. Yamamoto H, Kita H, Sunada K, Hayashi Y, Sato H, Yano T, et al. Clinical outcomes of double-balloon endoscopy for the diagnosis and treatment of small-intestinal diseases. Clin Gastroenterol Hepatol. 2004;2(11):1010–6.

    PubMed  Google Scholar 

  86. Ell C, May A, Nachbar L, Cellier C, Landi B, di Caro S, et al. Push-and-pull enteroscopy in the small bowel using the double-balloon technique: results of a prospective European multicenter study. Endoscopy. 2005;37(7):613–6.

    PubMed  CAS  Google Scholar 

  87. May A, Nachbar L, Ell C. Double-balloon enteroscopy (push-and-pull enteroscopy) of the small bowel: feasibility and diagnostic and therapeutic yield in patients with suspected small bowel disease. Gastrointest Endosc. 2005;62(1):62–70.

    PubMed  Google Scholar 

  88. Numata M, Kodama M, Sasaki F, Murayama T, Tsubouchi N, Uto H, et al. Usefulness of double balloon endoscopy as a diagnostic and therapeutic method for small-intestinal involvement in patients with inflammatory bowel disease [abstract S1488]. Gastrointest Endosc. 2007;65(5):AB188.

    Google Scholar 

  89. Oshitani N, Yukawa T, Yamagami H, Inagawa M, Kamata N, Watanabe K, et al. Evaluation of deep small bowel involvement by double-balloon enteroscopy in Crohn’s disease. Am J Gastroenterol. 2006;101(7):1484–9.

    PubMed  Google Scholar 

  90. Pasha SF, Leighton JA, Das A, et al. Double balloon enteroscopy and capsule endoscopy have comparable diagnostic yield in small bowel: a meta-analysis. Clin Gastroenterol Hepatol. 2008;6(6):671–6.

    PubMed  Google Scholar 

  91. Sunada K, Yamamoto H, Kita H, Yano T, Sato H, Hayashi Y, et al. Clinical outcomes of enteroscopy using the double-balloon method for strictures of the small intestine. World J Gastroenterol. 2005;11(7):1087–9.

    PubMed  Google Scholar 

  92. D’Haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn’s disease: a European multicenter trial. Gastroenterology. 1999;116(5):1029–34.

    PubMed  Google Scholar 

  93. Monkemuller K, Fry LC, Ebert M, Bellutti M, Venerito M, Knippig C, et al. Feasibility of double-balloon enteroscopy-assisted chromoendoscopy of the small bowel in patients with familial adenomatous polyposis. Endoscopy. 2007;39(1):52–7.

    PubMed  CAS  Google Scholar 

  94. Kenji W, Hosomi S, Hirata N, Yukawa T, Kamata N, Yamagami H, et al. Useful diagnostic strategy in combination capsule endoscopy with double balloon endoscopy for Crohn’s disease. Paper presented at International Conference of Capsule Endoscopy, Paris, France; 9–10 June 2006.

    Google Scholar 

  95. Attar A, Maissiat E, Sebbagh V, Cellier C, Wind P, Benamouzig R. First case of paralytic intestinal ileus after double balloon enteroscopy. Gut. 2005;54(12):1823–4.

    PubMed  CAS  Google Scholar 

  96. Groenen MJ, Moreels TG, Orlent H, Haringsma J, Kuipers EJ. Acute pancreatitis after double-balloon enteroscopy: an old pathogenetic theory revisited as a result of using a new endoscopic tool. Endoscopy. 2006;38(1):82–5.

    PubMed  CAS  Google Scholar 

  97. Itzkowitz SH, Present DH. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(3):314–21.

    PubMed  Google Scholar 

  98. Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology. 1992;103(5):1611–20.

    PubMed  CAS  Google Scholar 

  99. Rutter M, Bernstein C, Matsumoto T, Kiesslich R, Neurath M. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy. 2004;36(12):1109–14.

    PubMed  CAS  Google Scholar 

  100. van Rijn AF, Samsom M, Oldenburg B. Adherence to surveillance guidelines for dysplasia and colonic carcinoma in ulcerative and Crohn’s colitis patients in the Netherlands [abstract M1174]. Gastroenterology. 2005;128(4 Suppl 2):A-324.

    Google Scholar 

  101. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology. 2004;126(6):1634–48.

    PubMed  Google Scholar 

  102. Dekker E, Fockens P. New endoscopic tools for the IBD physician. Inflamm Bowel Dis. 2004;10 Suppl 1:S7–10.

    PubMed  Google Scholar 

  103. Jung M, Kiesslich R. Chromoendoscopy and intravital staining techniques. Baillières Best Pract Res Clin Gastroenterol. 1999;13(1):11–9.

    PubMed  CAS  Google Scholar 

  104. Kiesslich R, Goetz M, Vieth M, Galle PR, Neurath MF. Technology insight: confocal laser endoscopy for in vivo diagnosis of colorectal cancer. Nat Clin Pract Oncol. 2007;4(8):480–90.

    PubMed  Google Scholar 

  105. Kiesslich R, Fritsch J, Holtmann M, Koehler HH, Stolte M, Kanzler S, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology. 2003;124(4):880–8.

    PubMed  Google Scholar 

  106. Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004;53(2):256–60.

    PubMed  CAS  Google Scholar 

  107. Kiesslich R, Burg J, Vieth M, Gnaendiger J, Enders M, Delaney P, et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology. 2004;127(3):706–13.

    PubMed  Google Scholar 

  108. Kiesslich R, Goetz M, Lammersdorf K, Schneider C, Burg J, Stolte M, et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology. 2007;132(3):874–82.

    PubMed  Google Scholar 

  109. Sakashita M, Inoue H, Kashida H, Tanaka J, Cho JY, Satodate H, et al. Virtual histology of colorectal lesions using laser-scanning confocal microscopy. Endoscopy. 2003;35(12):1033–8.

    PubMed  CAS  Google Scholar 

  110. Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt. 2004;9(3):568–77.

    PubMed  Google Scholar 

  111. Machida H, Sano Y, Hamamoto Y, Muto M, Kozu T, Tajiri H, et al. Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study. Endoscopy. 2004;36(12):1094–8.

    PubMed  CAS  Google Scholar 

  112. Dekker E, van den Broek FJ, Reitsma JB, Hardwick JC, Offerhaus GJ, van Deventer SJ, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy. 2007;39(3):216–21.

    PubMed  CAS  Google Scholar 

  113. Shen B, Zuccaro Jr G, Gramlich TL, Gladkova N, Trolli P, Kareta M, et al. In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2(12):1080–7.

    PubMed  Google Scholar 

  114. Familiari L, Strangio G, Consolo P, Luigiano C, Bonica M, Barresi G, et al. Optical coherence tomography evaluation of ulcerative colitis: the patterns and the comparison with histology. Am J Gastroenterol. 2006;101(12):2833–40.

    PubMed  Google Scholar 

  115. Leighton JA, Loftus Jr EV. Evolving diagnostic modalities in inflammatory bowel disease. Curr Gastroenterol Rep. 2005;7(6):467–74.

    PubMed  Google Scholar 

  116. Paulsen SR, Huprich JE, Hara AK. CT enterography: noninvasive evaluation of Crohn’s disease and obscure gastrointestinal bleed. Radiol Clin North Am. 2007;45(2):303–15.

    PubMed  Google Scholar 

  117. Wold PB, Fletcher JG, Johnson CD, Sandborn WJ. Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy – feasibility study. Radiology. 2003;229(1):275–81.

    PubMed  Google Scholar 

  118. Choi D, Jin Lee S, Ah Cho Y, Lim HK, Hoon Kim S, Jae Lee W, et al. Bowel wall thickening in patients with Crohn’s disease: CT patterns and correlation with inflammatory activity. Clin Radiol. 2003;58(1):68–74.

    PubMed  Google Scholar 

  119. Zalis M, Singh AK. Imaging of inflammatory bowel disease: CT and MR. Dig Dis. 2004;22(1):56–62.

    PubMed  Google Scholar 

  120. Chiorean MV, Sandrasegaran K, Saxena R, Maglinte DD, Nakeeb A, Johnson CS. Correlation of CT enteroclysis with surgical pathology in Crohn’s disease. Am J Gastroenterol. 2007;102(11):2541–50.

    PubMed  Google Scholar 

  121. Mazzeo S, Caramella D, Battolla L, Melai L, Masolino P, Bertoni M, et al. Crohn disease of the small bowel: spiral CT evaluation after oral hyperhydration with isotonic solution. J Comput Assist Tomogr. 2001;25(4):612–6.

    PubMed  CAS  Google Scholar 

  122. Bodily KD, Fletcher JG, Solem CA, Johnson CD, Fidler JL, Barlow JM, et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT Enterography – correlation with endoscopic and histologic findings of inflammation. Radiology. 2006;238(2):505–16.

    PubMed  Google Scholar 

  123. Del Campo L, Arribas I, Valbuena M, Mate J, Moreno-Otero R. Spiral CT findings in active and remission phases in patients with Crohn disease. J Comput Assist Tomogr. 2001;25(5):792–7.

    PubMed  Google Scholar 

  124. Mako EK, Mester AR, Tarjan Z, Karlinger K, Toth G. Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel Crohn’s disease. Eur J Radiol. 2000;35(3):168–75.

    PubMed  CAS  Google Scholar 

  125. Hassan C, Cerro P, Zullo A, Spina C, Morini S. Computed tomography enteroclysis in comparison with ileoscopy in patients with Crohn’s disease. Int J Colorectal Dis. 2003;18(2):121–5.

    PubMed  Google Scholar 

  126. Wiarda BM, Kuipers EJ, Heitbrink MA, van Oijen A, Stoker J. MR Enteroclysis of inflammatory small-bowel diseases. AJR Am J Roentgenol. 2006;187(2):522–31.

    PubMed  Google Scholar 

  127. Laghi A, Paolantonio P, Passariello R. Small bowel. Magn Reson Imaging Clin N Am. 2005;13(2):331–48.

    PubMed  Google Scholar 

  128. Rieber A, Wruk D, Potthast S, Nussle K, Reinshagen M, Adler G, et al. Diagnostic imaging in Crohn’s disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis. 2000;15(3):176–81.

    PubMed  CAS  Google Scholar 

  129. Ochsenkuhn T, Herrmann K, Schoenberg SO, Reiser MF, Goke B, Sackmann M. Crohn disease of the small bowel proximal to the terminal ileum: detection by MR-enteroclysis. Scand J Gastroenterol. 2004;39(10):953–60.

    PubMed  CAS  Google Scholar 

  130. Golder SK, Schreyer AG, Endlicher E, Feuerbach S, Scholmerich J, Kullmann F, et al. Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease. Int J Colorectal Dis. 2006;21(2):97–104.

    PubMed  Google Scholar 

  131. Tarjan Z, Zagoni T, Gyorke T, Mester A, Karlinger K, Mako EK. Spiral CT colonography in inflammatory bowel disease. Eur J Radiol. 2000;35(3):193–8.

    PubMed  CAS  Google Scholar 

  132. Biancone L, Fiori R, Tosti C, Marinetti A, Catarinacci M, De Nigris F, et al. Virtual colonoscopy compared with conventional colonoscopy for stricturing postoperative recurrence in Crohn’s disease. Inflamm Bowel Dis. 2003;9(6):343–50.

    PubMed  Google Scholar 

  133. Schreyer AG, Rath HC, Kikinis R, Volk M, Scholmerich J, Feuerbach S, et al. Comparison of magnetic resonance imaging colonography with conventional colonoscopy for the assessment of intestinal inflammation in patients with inflammatory bowel disease: a feasibility study. Gut. 2005;54(2):250–6.

    PubMed  CAS  Google Scholar 

  134. Ajaj WM, Lauenstein TC, Pelster G, Gerken G, Ruehm SG, Debatin JF, et al. Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity. Gut. 2005;54(2):257–63.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic in Arizona, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA

    Jonathan A. Leighton

Authors
  1. Shabana F. Pasha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan A. Leighton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan A. Leighton .

Editor information

Editors and Affiliations

  1. MC 4076, Sect. Of GE, Hepatol. & Nutr., Department of Medicine, University of Chicago Medical Center, S. Maryland Ave. 5841, Chicago, 60637, Illinois, USA

    Russell D. Cohen

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Pasha, S.F., Leighton, J.A. (2011). Novel Techniques in the Diagnosis of Inflammatory Bowel Disease. In: Cohen, R. (eds) Inflammatory Bowel Disease. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-433-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-433-3_15

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-432-6

  • Online ISBN: 978-1-60327-433-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation